Skip to main content

Advertisement

Table 3 Prevalence of anaemia as affected by sociodemographic and clinical factors in HIV positive and HIV negative participants

From: Malaria parasite prevalence and Haematological parameters in HIV seropositive patients attending the regional hospital Limbe, Cameroon: a hospital-based cross-sectional study

CategoriesHIV PositiveHIV NegativeOverall
nAnaemia prevalence (n)χ2
P
nAnaemia prevalence (n)χ2
P
NAnaemia prevalence (n)χ2
P
Gender
 Female23864.7(154)31.96149.2(30)5.1629961.5(184)39.4
 Male7126.8(19)0.001*4126.8(11)0.02*11226.8(3 + 0)< 0.001*
Age group (years)
  ≤ 251154.5(6)1.154852.1(25)5.375952.5(31)0.34
 26–4015659.0(92)0.563528.6(10)0.0719153.4(102)0.84
  > 4014252.8(75) 1931.6(6) 16150.3(81) 
Malaria status
 Malaria positive2479.2(19)5.673447.1(16)0.995860.3(35)1.85
 Malaria negative28554.0(154)0.016836.9(25)0.2235350.7(79)0.11
Fever status
 Febrile1656.2(9)0.0011855.6(10)χ2 = 2.143455.9(19)0.21
 Afebrile29356.0(164)0.508436.9(31)P = 0.1137751.7(195)0.38
ARV use
 Yes29255.5(162)0.55   29255.5(162)0.55
 No1764.7(11)0.31   1764.7(11)0.31
Duration on ARV
  < 12 months3363.6(21)0.86   3363.6(21)0.86
 12–35 months8256.1(46)0.42   8256.1(46)0.42
  ≥ 36 months19155.0(105)    19155.0(105) 
CD4T-cell (cells/μl)
  < 2004173.2(30)3.78   4173.2(30)3.78
 200–4997160.6(43)0.05   7160.6(43)0.05
  ≥ 5006154.1(33)    6154.1(33) 
  1. * statistically significant P value